Study Finds Faulty Gene Doesn’t Affect Breast Cancer Survival Rates

Breast Cancer Ribbon

When it comes to serious health issues like breast cancer, it can be difficult to get the facts straight on fundamental questions: What risk factors should I be concerned about? What procedure should I get if I do get breast cancer? Am I more or less likely to be at risk if I follow a specific health regimen? Those are all vital questions that deserve careful consideration

Recently, a study published in The Lancet Oncology answered at least one of these questions, after finding that young patients with faulty BRCA genes have breast cancer survival rates that are comparable to those with non-faulty BRCA genes. These genes, which increase a woman’s risk of developing breast cancer, made headlines in 2013 when actress Angelina Jolie underwent a preventative mastectomy after discovering she had a faulty BRCA gene.

This study suggests that women with BRCA gene mutations have more time to decide whether or not to undergo mastectomy surgeries than physicians previously assumed.

As with any life-changing procedure, additional time to think can be of great value to breast cancer patients. However, it’s worth noting that among women with faulty BRCA genes, preventive mastectomies are still considered the common course of treatment. This study did not look at whether these preventative mastectomies affected survival rates.

At South Avenue Women’s Services, we know it can be difficult and even frightening to face tough questions about your health. That’s why our staff is dedicated to providing safe and effective services to anyone who walks in our door, and providing our clients with the information they need to make informed healthcare decisions.